Predicting of the development of aids-indicating opportunistic infections in HIV-infected patients on antiretroviral therapy (retrospective cohort study)

Authors

DOI:

https://doi.org/10.15587/2519-4798.2019.179650

Keywords:

HIV infection, AIDS-indicating opportunistic infections on antiretroviral therapy, prognosis

Abstract

HIV remains one of the actual problems of modern medicine. The search for predictors of the development of AIDS-associated opportunistic infections (OI) in patients on antiretroviral therapy (ART) is an urgent scientific and practical task.

The aim of the study was to investigate the predictors of progression and to create a prognostic model for the development of AIDS-related opportunistic infections in HIV-infected patients receiving ART based on the determination of clinical genetic markers.

Materials and methods. A retrospective cohort study of 181 HIV-infected patients was conducted. Logistic regression and ROC analysis were used for statistical data processing.

Results. As a result of the analysis of 27 potential predictors of the development of AIDS-associated OIs in patients on ART, 10 significant predictors were identified in HIV-infected patients, on which the progression of HIV depends, namely: male sex (OR = 3.30 [95% СΙ 1.21 –9.0], p = 0.020), injecting drugs (OR = 2.49 [95% SO 1.02–6.07], p = 0.044), incarceration experience (OR = 2.29 [95% CI 1.07–4.91], p = 0.033), smoking (OR = 2.46 [95% CI 1.14–5.27], p = 0.021), immunological failure of ART (OR = 4 , 48 [95% CI 1.98–10.13], p = 0.000), low adherence to ART (OR = 3.03 [95% CI 1.13–8.09], p = 0.027), BMI less 18.5 (OR = 6.13 [95% СΙ 2.77–13.56], p = 0.000), haemoglobin level lower than 100 g/L (OR = 2.99 [95% CI 1.41–6.32], p = 0.004), the 299Gly allele of the TLR4 gene carrying (OR = 3.38 [95% CI 1.41–8, 12], p = 0.006) and the normal genotype (Gln11Gln, 11Gln/-) of the TLR7 gene (OR = 2.90 [95% CI 1.06–7.95], p = 0.038).

Conclusions. A prognostic model of 5 predictors (male sex, immunological failure of ART, haemoglobin level lower than 100 g/L, BMI below 18.5 kg/m2 and carrier of the allele 299Gly of the TLR4 gene) was created (statistically significant (χ² = 59.88, g <0.001) with operational characteristics: sensitivity - 73.0%, specificity - 79.0% and had a high predictive efficiency (area under the ROC curve - 0.8580)

Author Biography

Olena Marchenko, Ukrainian Academy of Medical Dental Shevchenko str., 23, Poltava, Ukraine, 36011

Postgraduate Student

Department of Infectious Diseases with Epidemiology

References

  1. Global AIDS monitoring 2019: UNAIDS (2019). Available at: http://www.unaids.org/sites/default/files/media_asset/global-aids-monitoring_en.pdf
  2. VIL-infektsiia v Ukraini. Informatsiinyi biuleten No. 48 (2017). Kyiv: Derzhavna ustanova «Ukrainskyi tsentr kontroliu za sotsialno nebezpechnymy khvorobamy Ministerstva okhorony zdorovia Ukrainy», 39. Available at: https://phc.org.ua/sites/default/files/users/user90/HIV_in_UA_48_2017.pdf
  3. Cox, J. A., Kiggundu, D., Elpert, L., Meintjes, G., Colebunders, R., Alamo, S. (2016). Temporal trends in death causes in adults attending an urban HIV clinic in Uganda: a retrospective chart review. BMJ Open, 6 (1), e008718. doi: http://doi.org/10.1136/bmjopen-2015-008718
  4. Da Silva Escada, R. O., Velasque, L., Ribeiro, S. R., Cardoso, S. W., Marins, L. M. S., Grinsztejn, E. et. al. (2017). Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil – associated factors and causes of death. BMC Infectious Diseases, 17 (1). doi: http://doi.org/10.1186/s12879-017-2473-y
  5. Luo, B., Sun, J., Cai, R., Shen, Y., Liu, L., Wang, J. et. al. (2016). Spectrum of Opportunistic Infections and Risk Factors for In-Hospital Mortality of Admitted AIDS Patients in Shanghai. Medicine, 95 (21), e3802. doi: http://doi.org/10.1097/md.0000000000003802
  6. Van Rie, A., Westreich, D., Sanne, I. (2011). Tuberculosis in Patients Receiving Antiretroviral Treatment: Incidence, Risk Factors, and Prevention Strategies. JAIDS Journal of Acquired Immune Deficiency Syndromes, 56 (4), 349–355. doi: http://doi.org/10.1097/qai.0b013e3181f9fb39
  7. Gunda, D. W., Maganga, S. C., Nkandala, I., Kilonzo, S. B., Mpondo, B. C., Shao, E. R., Kalluvya, S. E. (2018). Prevalence and Risk Factors of Active TB among Adult HIV Patients Receiving ART in Northwestern Tanzania: A Retrospective Cohort Study. Canadian Journal of Infectious Diseases and Medical Microbiology, 2018, 1–7. doi: http://doi.org/10.1155/2018/1346104
  8. Solomon, F. B., Angore, B. N., Koyra, H. C., Tufa, E. G., Berheto, T. M., Admasu, M. (2018). Spectrum of opportunistic infections and associated factors among people living with HIV/AIDS in the era of highly active anti-retroviral treatment in Dawro Zone hospital: a retrospective study. BMC Research Notes, 11 (1). doi: http://doi.org/10.1186/s13104-018-3707-9
  9. Koval, T., Dubynska, G. (2017). Prognosos of HIV-infection progression and the search for the predictors of aids and pulmonary tuberculosis development. ScienceRise: Medical Science, 10 (18), 16–19. doi: http://doi.org/10.15587/2519-4798.2017.113319
  10. Pro zatverdzhennia klinichnoho protokolu antyretrovirusnoi terapii VIL-infektsii u doroslykh ta pidlitkiv (2010). Nakaz MOZ Ukrainy No. 551. 12.07.2010. Available at: https://zakon.rada.gov.ua/rada/show/v0551282-10
  11. Klinichnyi protokol diahnostyky ta likuvannia oportunistychnykh infektsii i zahalnykh symptomiv u doroslykh ta pidlitkiv (2007). Nakaz MOZ Ukrainy No. 182. 13.04.2007. Available at: https://zakon.rada.gov.ua/rada/file/docs/4/d242884.doc
  12. Wilkinson, R. J., Walker, N. F., Scriven, J., Meintjes, G. (2015). Immune reconstitution inflammatory syndrome in HIV-infected patients. HIV/AIDS – Research and Palliative Care, 49. doi: http://doi.org/10.2147/hiv.s42328
  13. Crabtree-Ramírez, B., Caro-Vega, Y., Shepherd, B. E., Wehbe, F., Cesar, C. et. al. (2011). Cross-Sectional Analysis of Late HAART Initiation in Latin America and the Caribbean: Late Testers and Late Presenters. PLoS ONE, 6 (5), e20272. doi: http://doi.org/10.1371/journal.pone.0020272
  14. Komati, S., Shaw, P. A., Stubbs, N., Mathibedi, M. J., Malan, L., Sangweni, P. et. al. (2010). Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa. AIDS, 24 (12), 1849–1855. doi: http://doi.org/10.1097/qad.0b013e32833a2507
  15. Weissberg, D., Mubiru, F., Kambugu, A., Fehr, J., Kiragga, A., von Braun, A. et. al. (2018). Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort. PLOS ONE, 13 (11), e0206796. doi: http://doi.org/10.1371/journal.pone.0206796
  16. Sharma, A., Hoover, D. R., Shi, Q., Gustafson, D., Plankey, M. W., Hershow, R. C. et. al. (2015). Relationship between body mass index and mortality in HIV-infected HAART users in the women's interagency HIV study. PLOS ONE, 10(12), e0143740. doi: http://doi.org/10.1371/journal.pone.0143740

Published

2019-10-10

How to Cite

Marchenko, O. (2019). Predicting of the development of aids-indicating opportunistic infections in HIV-infected patients on antiretroviral therapy (retrospective cohort study). ScienceRise: Medical Science, (5 (32), 11–17. https://doi.org/10.15587/2519-4798.2019.179650

Issue

Section

Medical Science